From the Agenda
The last hurdle? : Management and strategies for preparing a Biosimilar dossier
Scientific and Regulatory Affairs Manager
PhD in Biomedicine.
Academic research in gene therapy, regeneration and
muscular dystrophy, diabetes.
He has published numerous original research
papers and review articles in peer reviewed journals.
Expert in medical and scientific writing for
Biosimilars, Innovative, Biological, Biotechnological, and Advanced Therapy
Medicinal Products, including gene and somatic cell therapies.
Currently working in medical writing for Paediatric
Investigation Plans, Scientific Advice/Pre-IND meetings and Centralized
Experience in Biosimilars CP writing Clinical and
World wide experience in Biosimilars Gap
Analysis and writing.